SABS News and Press, SAB Biotherapeutics Inc. From 11/05/25

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that four oral presentations and t...

MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its lead program in clinical development for delaying the progression of type...

-As SAB initiates its Phase 2b SAFEGUARD study for SAB-142 in new-onset Stage 3 autoimmune T1D patients, EASD provided an opportunity to connect with many T1D thought leaders that will participate in the study- -Data in multiple SAB presentations and INNODIA’s MELD-ATG study provid...

MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a multi-specific human anti-thymocyte immunoglobulin...

2025-09-02 17:31:07 ET More on SAB Biotherapeutics Seeking Alpha’s Quant Rating on SAB Biotherapeutics Historical earnings data for SAB Biotherapeutics Financial information for SAB Biotherapeutics Read the full article on Seeking Alpha For fur...

SAB Biotherapeutics Inc. (SABS) is expected to report $-0.82 for Q2 2025

Recently raised $175 million in oversubscribed private placement which included strategic investor Sanofi and top-tier biotech investors Strong cash position with completed financing extending operational runway until the middle of 2028 Achieved alignment with FDA on the design an...

A look at the top 10 most actives in the United States TNF Pharmaceuticals Inc. (TNFA) rose 23.2% to $0.1078 on volume of 199,508,382 shares NuCana plc (NCNA) rose 8.0% to $0.0515 on volume of 192,535,191 shares Opendoor Technologies Inc (OPEN) rose 22.9% to $2.765 on volume of 183,615,622 ...

2025-07-21 09:27:18 ET DENVER, Colo., Jul 21, 2025 ( 247marketnews.com )- The biotech sector is buzzing with momentum as a new wave of innovation drives investor attention toward companies pushing the frontier across diverse domains; from brain health and autoimmune therapies to regener...